Guyatt, G, Montori, V, Devereaux, PJ, Schunemann, H, Bhandari, M. Patients at the center: In our practice, and in our use of language. ACP J Club. 2004;140:A11–A12.
Johnston, BC, Donen, R, Pooni, A, et al.
Conceptual framework for health-related quality of life assessment in acute gastroenteritis. J Pediatr Gastroenterol Nutr. 2013;56:280–289.
Fayers, P, Machin, D. Quality of life: The assessment, analysis and interpretation of patient-reported outcomes. New York: John Wiley & Sons; 2013.
Rahimi, K, Malhotra, A, Banning, AP, Jenkinson, C. Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: Systematic review. BMJ. 2010;341:c5707.
Kalyoncu, U, Dougados, M, Daures, JP, Gossec, L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review. Ann Rheum Dis. 2009;68:183–190.
Reeve, BB, Wyrwich, KW, Wu, AW, et al.
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013;22:1889–1905.
Magasi, S, Ryan, G, Revicki, D, et al.
Content validity of patient-reported outcome measures: Perspectives from a PROMIS meeting. Qual Life Res. 2012;21:739–746.
Hsieh, HF, Shannon, SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–1288.
Creswell, JW. Qualitative inquiry and research design: Choosing among the five traditions. Thousand Oaks: Sage Publications, Inc; 1998.
Wiebe, S, Guyatt, G, Weaver, B, Matijevic, S, Sidwell, C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56:52–60.
Schunemann, HJ, Guyatt, GH. Commentary–goodbye M(C)ID! Hello MID, where do you come from?
Health Serv Res. 2005;40:593–597.
Guyatt, GH, Osoba, D, Wu, AW, Wyrwich, KW, Norman, GR. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77:371–383.
Guyatt, GH, Juniper, EF, Walter, SD, Griffith, LE, Goldstein, RS. Interpreting treatment effects in randomised trials. BMJ. 1998 Feb 28;316:690–693.
Norman, GR, Sloan, JA, Wyrwich, KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care. 2003;41:582–592.
Ware, JE Jr.
SF-36 health survey update. Spine. 2000;25:3130–3139.
Sullivan, M, Karlsson, J, Ware, JE Jr. The Swedish SF-36 Health Survey–I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 1995;41:1349–1358.
Schermuly, I, Muller, MJ, Muller, KM, et al.
Neuropsychiatric symptoms and brain structural alterations in Fabry disease. Eur J Neurol. 2011;18:347–353.
Kosinski, M, Zhao, SZ, Dedhiya, S, Osterhaus, JT, Jr, Ware JE. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis Rheum. 2000;43:1478–1487.
Szende, A, Oppe, M, Devlin, NJ, editors. EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht, The Netherlands: Springer; 2007.
Walters, SJ, Brazier, JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–1532.
Cleeland, CS, Ryan, KM. Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129–138.
Dworkin, RH, Turk, DC, Wyrwich, KW, et al.
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105–121.
Melzack, R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191–197.
Ro, LS, Chen, CM, Chang, HS, et al.
Contribution of clinical screening to carrier detection in a large Chinese family with Fabry disease due to a novel alpha-galactosidase A gene deletion. Eur J Neurol. 2007;14:493–497.
Krupp, LB, LaRocca, NG, Muir-Nash, J, Steinberg, AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–1123.
Merkies, IS, Schmitz, PI, Samijn, JP, van der Meche, FG, van Doorn, PA. Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology. 1999;53:1648–1654.
Singh, G, Athreya, B, Fries, JF, Goldsmith, DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum. 1994;37:1761–1769.
Nugent, J, Ruperto, N, Grainger, J, et al.
The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol. 2001;19
Dempster, H, Porepa, M, Young, N, Feldman, BM. The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum. 2001;44:1768–1774.
Merkies, IS, Schmitz, PI, Van Der Meche, FG, Samijn, JP, Van Doorn, PA. Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies. Muscle Nerve. 2002;25:370–377.
Hagemans, ML, Laforet, P, Hop, WJ, et al.
Impact of late-onset Pompe disease on participation in daily life activities: Evaluation of the Rotterdam Handicap Scale. Neuromuscul Disord. 2007; 17:537–543.
Johnston, BC, Miller, PA, Agarwal, A, et al.
Limited responsiveness related to the minimal important difference of patient-reported outcomes in rare diseases. J Clin Epidemiol. 2016; Jul 2. pii: S0895-4356(16)30187-1. doi: 10.1016/j.jclinepi.2016.06.010. [Epub ahead of print]